Literature DB >> 27544302

Management of non-clear cell renal cell carcinoma: Current approaches.

Ilya Tsimafeyeu1.   

Abstract

Non-clear cell renal cell carcinoma includes several histological variants. Tumor biology has significant effect on the duration of the disease. Prognosis at formally similar disease stages may differ despite same surgical treatment approaches to clear and non-clear cell renal cell carcinomas. Tumor sensitivity to pharmacotherapy also depends on the histological subtype. This article offers detailed discussion on current treatment options for patients with papillary, chromophobe, and other types of renal cell carcinoma.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Classification; Non–clear cell renal cell carcinoma; Prognosis; Surgical treatment; Targeted therapy

Mesh：

Substances：

Year:  2016        PMID： 27544302     DOI： 10.1016/j.urolonc.2016.07.011

Source DB:  PubMed          Journal:  Urol Oncol        ISSN： 1078-1439            Impact factor:   3.498


  4 in total

1.  Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma.

Authors:  Jii Bum Lee; Hyung Soon Park; Sejung Park; Hyo Jin Lee; Kyung A Kwon; Young Jin Choi; Yu Jung Kim; Chung Mo Nam; Nam Hoon Cho; Beodeul Kang; Hyun Cheol Chung; Sun Young Rha
Journal:  Cancer Res Treat       Date:  2019-04-16       Impact factor: 4.679

2.  Real-world evidence on first-line treatment for metastatic renal cell carcinoma with non-clear cell and sarcomatoid histologies: are sunitinib and pazopanib interchangeable?

Authors:  Renata Colombo Bonadioa; Pedro Isaacsson Velho; Guilherme Nader Marta; Mirella Nardo; Manoel Carlos LA Souza; David Qb Muniz; Regis Of Bezerra; Raisa Ka Bispo; Sheila F Faraj; Diogo A Bastos; Carlos Dzik
Journal:  Ecancermedicalscience       Date:  2019-11-04

3.  Heterogeneity of tumor microenvironment is associated with clinical prognosis of non-clear cell renal cell carcinoma: a single-cell genomics study.

Authors:  Wen-Jin Chen; Hao Cao; Jian-Wei Cao; Li Zuo; Fa-Jun Qu; Da Xu; Hao Zhang; Hai-Yi Gong; Jia-Xin Chen; Jian-Qing Ye; Si-Shun Gan; Wang Zhou; Da-Wei Zhu; Xiu-Wu Pan; Xin-Gang Cui
Journal:  Cell Death Dis       Date:  2022-01-11       Impact factor: 8.469

4.  Identification of an immune-related gene prognostic index for predicting survival and immunotherapy efficacy in papillary renal cell carcinoma.

Authors:  Dongshan Chen; Chen Zhang; Yuanwei Zang; Wei Wang; Jiandong Zhang
Journal:  Front Genet       Date:  2022-08-29       Impact factor: 4.772
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.